CRISPR technique can target single genes essential for cancer cell survival, toppling the whole structure, says nanomedicine ...

Beam Therapeutics said it used a form of CRISPR called base editing to correct, in several patients, a mutation that drives a ...

Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing early investors to ...

Shares of CRISPR Therapeutics CRSP closed at $40.97 on Tuesday, close to their 52-week low of $36.52. This decline in CRSP ...

In 2008, Orkin, Sankaran, and colleagues achieved their vision by identifying a new therapeutic target for sickle cell disease. In December 2023, through the development efforts of CRISPR ...

The competition between U.S. and Chinese biotech companies is particularly fierce in one field: CRISPR gene editing. Here are ...

A recent review published in the journal Engineering delves into the significant advancements and potential of CRISPR ...

Development of a stem cell therapy for sickle cell disease from Vertex and development partner CRISPR therapeutics can go ahead, after the FDA lifted a hold on a review. The companies had applied ...

Her parents encouraged her to partake in a trial for a CRISPR -based therapy for sickle-cell disease and beta-thalassemia, another debilitating genetic blood disorder. The therapy, Casgevy, was made ...

CRISPR Therapeutics' stock faces challenges with slow Casgevy adoption and competition. See how CRSP stock remains a cautious ...

A recent Vanderbilt study has found a cure for sickle cell disease, a blood disorder where the body creates mutated red blood ...